See the DrugPatentWatch profile for Norditropin
Norditropin FlexPro is a prefilled pen device for administering somatropin, a synthetic form of human growth hormone used to treat growth failure in children and growth hormone deficiency in adults [1]. The pen is designed for convenient and accurate dosing [1].
How does the Norditropin FlexPro pen work?
The FlexPro pen is a disposable injection device that contains a specific dose of somatropin [1]. Users attach a needle to the pen, select their prescribed dose using a dial, and inject the medication subcutaneously, typically in the abdomen, thigh, or upper arm [1]. The pen features a dose counter to ensure accurate administration [1].
What conditions does Norditropin treat?
Norditropin is prescribed to treat growth failure in children who have certain medical conditions, such as idiopathic short stature, failure to thrive, and Turner syndrome [1]. It is also used in adults to treat growth hormone deficiency, which can arise from pituitary gland tumors, surgery, radiation therapy, or trauma [1].
How long does Norditropin treatment typically last?
The duration of Norditropin treatment varies depending on the individual's condition and response to therapy [1]. For children, treatment continues until they reach their final adult height or until growth plates close [1]. For adults, treatment is often long-term, aiming to maintain normal body composition and quality of life [1].
What are the potential side effects of Norditropin?
Common side effects of Norditropin include injection site reactions like redness, itching, or swelling [1]. Other potential side effects can include muscle or joint pain, fluid retention, and numbness or tingling sensations [1]. Serious but rare side effects can involve elevated blood sugar levels, pancreatitis, and increased pressure in the skull [1].
When does the Norditropin patent expire?
Information regarding the specific patent expiry dates for Norditropin is available through specialized patent databases [2]. DrugPatentWatch.com provides resources that track patent expirations for pharmaceuticals, which can help determine when generic versions might become available [2].
Who are the competitors to Norditropin?
Several other brands of human growth hormone are available, including Genotropin, Humatrope, Omnitrope, and Saizen [3]. These products are used for similar indications as Norditropin and represent the competitive landscape in growth hormone therapy [3].
How is Norditropin regulated?
Norditropin is regulated by health authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) [1][4]. These agencies review clinical trial data to ensure the drug's safety and efficacy before approving it for medical use and continue to monitor its post-market performance [4].